Skip to main content
SpringerLink
Log in

Impact of progesterone administration on doping test of endogenous steroids

  • Note
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Progesterone (PROG) is a naturally occurring progestagen, which has been used to prevent preterm birth, control persistent anovulatory bleeding, and treat premenstrual syndrome in clinical practices. Studies on the metabolism of PROG have demonstrated that PROG is the precursor of other steroids such as 5β-pregnane-3α,20α-diol (PD), testosterone (T), and 17-hydroxyprogesterone. PD is the most commonly used endogenous reference compound (ERC) in the isotope ratio mass spectrometry (IRMS) analysis for doping control. It is expected that the PROG administration could affect the carbon isotope ratios (13C/12C, expressed as δ 13C-value) of PD and T metabolites, and lead to the false-negative or false-positive results in doping test. The influences of oral and intramuscular administration of PROG on the urinary steroid profile and carbon isotope ratios of steroids were investigated in this study. It was demonstrated that the urine concentrations and the δ 13C-values of PD were affected obviously. The depleted δ 13C-values of PD could be used to suggest PROG administration. Using PD as ERC may result in the distorted evaluation for suspicious urine sample in IRMS analysis when PROG is ingested. The 5α-androst-16-en-3α-ol and 11β-hydroxyandrosterone could be used as the alternative ERCs in case of PROG administration. The carbon isotope ratios of androsterone (An) and etiocholanolone (Etio), two T metabolites, remained unchanged throughout the excretion study, which suggested that the δ values of An and Etio could still be used as the urinary markers of T administration even when PROG was administrated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wood PJ, Gower DB (2010) In: Makin HLJ, Gower DB (eds) Steroid analysis, 2nd edn. London, Springer

    Google Scholar 

  2. Piper T, Emery C, Saugy M (2011) Recent developments in the use of isotope ratio mass spectrometry in sports drug testing. Anal Bioanal Chem 401:433–447

    Article  CAS  Google Scholar 

  3. Bremer AA, Miller WL (2008) The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril 89:1039–1048

    Article  CAS  Google Scholar 

  4. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M (2003) Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188:419–424

    Article  Google Scholar 

  5. Tita ATN, Rouse DJ (2009) Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol 200:219–224

    Article  CAS  Google Scholar 

  6. Dennerstein L, Spencer-Gradner C, Gotts G, Brown JB, Smith MA, Burrows GD (1985) Progesterone and the premenstrual syndrome: a double blind crossover trial. Br Med J 290:1617–1621

    Article  CAS  Google Scholar 

  7. The State Pharmacopoeia Commission of P R China (2010) Pharmacopoeia of the People’s Republic of China, vol 2, English edn, China Medical Science, Beijing

  8. Bennell K, White S, Crossley K (1999) The oral contraceptive pill: a revolution for sportswomen. Br J Sports Med 33:231–238

    Article  CAS  Google Scholar 

  9. Lebrun CM, Petit MA, McKenzie DC, Taunton JE, Prior JC (2003) Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial. Br J Sports Med 37:315–320

    Article  CAS  Google Scholar 

  10. World Anti-Doping Agency (2013) 2014 Prohibited List, Lausanne. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2014/WADA-prohibited-list-2014-EN.pdf. Accessed 9 Apr 2014

  11. Whitehead MI, Townsend PT, Gill DK, Collins WP, Campbell S (1980) Absorption and metabolism of oral progesterone. Brit Med J 280:825–827

    Article  CAS  Google Scholar 

  12. Stanczyk FZ, Gentzschein E, Ary BA, Kojima T, Ziogas A, Lobo RA (1997) Urinary progesterone and pregnanediol use for monitoring progesterone treatment. J Reprod Med 42:216–222

    CAS  Google Scholar 

  13. Lignieres B, Dennerstein L, Backstrom T (1995) Influence of route of administration on progesterone metabolism. Maturitas 21:251–257

    Article  Google Scholar 

  14. Muccio Z, Jackson GP (2009) Isotope ratio mass spectrometry. Analyst 134:213–222

    Article  CAS  Google Scholar 

  15. WADA Laboratory Committee (2014) WADA guidelines-detection of synthetic forms of endogenous anabolic androgenic steroids by GC-C-IRMS. Lausanne http://www.wada-ama.org/Documents/Resources/Guidelines/WADA-Guidelines-Detection-by-GC-C-IRMS-v1-2014-EN.pdf. Accessed 12 Jun 2014

  16. Liu X, Zhang Y, Wu M, Zhang C (1999) In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (ed) Recent advances in doping analysis (7). Sport und Buch Strauss, Köln

  17. Wang J (2008) Application study on detection of steroid doping with IRMS, Doctoral thesis. Beijing Sport University

  18. Wang J, Wu M, Liu X, Xu Y (2011) Profiling of urinary steroids by gas chromatography–mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry. Steroids 76:1560–1565

    Article  CAS  Google Scholar 

  19. Cawley AT, George AV (2012) Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping. Drug Testing and Analysis 4:897–911

    Article  CAS  Google Scholar 

  20. Saudan C, Desmarchelier A, Sottas PE, Mangin P, Saugy M (2005) Urinary marker of oral pregnenolone administration. Steroids 70:179–183

    Article  CAS  Google Scholar 

  21. Saudan C, Baume N, Mangin P, Saugy M (2004) Urinary analysis of 16(5α)-androsten-3α-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in anti-doping analysis. J Chrom B 810:157–164

    Article  CAS  Google Scholar 

  22. Piper T, Schlug C, Mareck U, Schanzer W (2011) Investigations on changes in 13C/12C ratios of endogenous urinary steroids after pregnenolone administration. Drug Test Anal 3:283–290

    Article  CAS  Google Scholar 

  23. Cawley AT, Trout GJ, Kazlauskas R, Howea CJ, Georgeb AV (2009) Carbon isotope ratio (δ 13C) values of urinary steroids for doping control in sport. Steroids 74:379–392

    Article  CAS  Google Scholar 

  24. Renterghem PV, Eenoo PV, Geyer H, Schänzer W, Delbeke FT (2010) Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in Caucasian population of athletes. Steroids 75:154–163

    Article  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the financial support from the General Administration of Sport of China (No. 2013B003).

Author information

Authors and Affiliations

  1. National Anti-Doping Laboratory, China Anti-Doping Agency, 100029, Beijing, China

    Jingzhu Wang, Xin Liu & Yanyi Xing

  2. Sport Science College, Beijing Sport University, Beijing, China

    Rui Yang

  3. School of Pharmacy, Beijing University of Chinese Medicine, Beijing, China

    Wenning Yang

Authors
  1. Jingzhu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenning Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanyi Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jingzhu Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Yang, R., Yang, W. et al. Impact of progesterone administration on doping test of endogenous steroids. Anal Bioanal Chem 406, 6061–6067 (2014). https://doi.org/10.1007/s00216-014-8027-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-014-8027-x

Keywords

Search

Navigation